Bergapten

DB12216InvestigationalSmall molecule

Bergapten is under investigation in clinical trial NCT00533195 (Comparison of UVA1 Phototherapy Versus Photochemotherapy for Patients With Severe Generalized Atopic Dermatitis).

Chemical structure of Bergapten
Mechanism
Curator reviewed
Formula / weight
C12H8O4 · 216.192 g/mol (avg)
Also known as
5 methoxypsoralen · 5-methoxypsoralen
Code names
NSC-95437

Resolves to

Compound
UNII4FVK84C92XCAS484-20-8ChEMBLCHEMBL24171ChEBI18293PubChem2355KEGGC01557
Clinical / RWD
RxNorm15842ATCD05BA03
Structure
InChIKeyBGEBZHIAGXMEMV-UHFFFAOYSA-NSMILESCOC1=C2C=CC(=O)OC2=CC2=C1C=CO2
Targets
Q6P988NOTUM

What you can answer from here — as of October 24, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
21Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1ATC codeIncluding every combination product, plus 17 drug categories
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Bergapten, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In